Results 21 to 30 of about 1,309,506 (180)
Current Oncology, 2023 Chemotherapy-induced nausea and vomiting (CINV) negatively impact cancer patients’ quality of life and treatment outcomes. This study evaluated the achievement of complete response to CINV prophylaxis during the first five days after chemotherapy in ...
António Araújo +8 more
doaj +1 more source
Cancer Reports, 2022 Background Chemotherapy‐induced nausea and vomiting (CINV) is a major concern of patients with cancer, leading to suboptimal treatment. Aim This study assessed the emetic risk associated with intravenous and oral chemotherapy and the prophylactic ...
Ayako Okuyama +2 more
doaj +1 more source
Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2023 Aims: Describing the adherence rate of antiemetic prophylaxis in pediatric patients using antineoplastic agents and possible associated factors. Methods: It is a retrospective cross-sectional study, which took place in a teaching hospital at Belo ...
Safira R. ALVES +5 more
doaj +1 more source
The Effect of Transdermal Scopolamine for the Prevention of Postoperative Nausea and Vomiting
Frontiers in Pharmacology, 2014 Postoperative nausea and vomiting is one of the most common and undesirable complaints recorded in as many as 70%-80% of high-risk surgical patients. The current prophylactic therapy recommendations for PONV management stated in the Society of Ambulatory
Maria A. Antor +7 more
doaj +1 more source
, 2017 This paper reports prescribing patterns for prophylaxis of chemotherapy-induced nausea and vomiting (CINV) after highly or moderately emetogenic chemotherapy (HEC or MEC) for cancer in six Asia Pacific countries. ;In a prospective noninterventional study,
Yu, Shiying;Burke, Thomas A.;Chan, Alexandre;Kim, Hoon-Kyo;Hsieh, Ruey Kuen;Hu, Xichun;Liang, Jin-Tung;Banos, Ana;Spiteri, Carmel;Keefe, Dorothy M. K. +1 more
core +1 more source
Antiemetic guidelines: are they being used?
, 2005 Evidence-based guidelines are regarded as therapeutic standards for many medical interventions. However, implementation of such recommendations seems to be rather difficult.
Kaiser, R.
core +1 more source
Effects of an Inpatient Program on Medication Errors in Hospitalized People with Parkinson's Disease
Annals of Neurology, EarlyView.Objective Hospitalized people with Parkinson's disease (PwP) face increased risks of medication errors and discharge to non‐home settings, both of which are associated with adverse outcomes. This study assessed differences in medication error rates and discharge outcomes before and after implementation of a dedicated inpatient program for hospitalized ...
Camila C. Piccinin +15 more
wiley +1 more source
Current Approaches to the Treatment of Diarrhea in Children
Zdorovʹe Rebenka, 2015 This article considers the current approaches to the treatment of acute diarrhea, taking into account the ESPGHAN guidelines (2014), which involves the use of oral rehydration therapy, zinc at a dose of 10 mg/day in children under 6 months, in children ...
О.S. Niankovska
doaj +1 more source
British Journal of Clinical Pharmacology, EarlyView.Patient‐reported outcomes (PROs) are essential for assessing clinical benefit and tolerability from the patient's perspective. In oncology trials, PRO data analysis often involves responder and time‐to‐event analyses, which depend on predefined thresholds to determine clinically meaningful change.
Anna Margarete Maria Thurner +5 more
wiley +1 more source
The Royal College of Ophthalmologists Guidelines on AMD: executive summary
, 2013 Age-related macular degeneration (AMD) is a common condition in older adults. Since publication of the last guidelines in 2009, new data have emerged on the management of AMD and novel solutions have been tested to meet the ongoing challenge of AMD ...
AMD Guidelines Group, +2 more
core +1 more source